Kaiser Permanente Oakland Medical Center — Oakland, California

Public research footprint of Kaiser Permanente Oakland Medical Center, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Carcinoma, Non-Small-Cell Lung · Mature B-Cell Non-Hodgkin Lymphoma · Acute Lymphoblastic Leukemia · COVID-19

Recently updated registry entries

NCT06973187 — A Study to Evaluate the Safety and Efficacy of BGB-16673 Compared to Pirtobrutinib in… (Recruiting)
NCT05533775 — A Study to Evaluate Glofitamab Monotherapy and Glofitamab + Chemoimmunotherapy in… (Recruiting)
NCT06667076 — A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Kaiser Permanente Oakland Medical Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.